drugset / Trial / NCT05431543
Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia
RandomizedCrossoverTriple-blindTreatment
Summary
To evaluate the safety and effectiveness of Aceclidine/Brimonidine (LNZ101) compared with Aceclidine (LNZ100) and vehicle in the treatment of Presbyopia.
Timeline
- Start
- 2022-08-06
- Primary completion
- 2022-12-14
- Completion
- 2022-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aceclidine | Small molecule | — | — |
| Subject | Brimonidine | Small molecule | — | — |